Guangdong Hongjing Optoelectronic Technology Inc.
301479
Longkou Union Chemical
301209
Zhejiang Realsun Chemical
301212
4
NEW JCM GROUP
300157
5
Shenzhen S-king Intelligent Equipment
688328
US Stock MarketDetailed Quotes
THAR Tharimmune
- 1.200
- -0.005-0.42%
Close Apr 25 16:00 ET
2.53MMarket Cap-0.13P/E (TTM)
1.230High1.190Low7.92KVolume1.230Open1.205Pre Close9.49KTurnover0.38%Turnover RatioLossP/E (Static)2.11MShares6.44952wk High1.94P/B2.49MFloat Cap0.95252wk Low--Dividend TTM2.08MShs Float1590.000Historical High--Div YieldTTM3.32%Amplitude0.952Historical Low1.198Avg Price1Lot Size
About Tharimmune Company
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or \"uncontrollable itching\" in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
Company Profile
SymbolTHAR
Company NameTharimmune
Listing DateJan 12, 2022
Founded2017
CEOMr. Randy Milby
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address1200 Route 22 East,Suite 2000
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807
Phone1-908-955-3140
Websitehttp://tharimmune.com
Company Executives
- Name
- Position
- Salary
- Randy Milby
- Chief Executive Officer and Chairman of the Board
- 742.42K
- Dong Kim
- Chief Financial Officer
- --
- Sireesh Appajosyula
- Director and Chief Operating Officer
- 8.48K
- Sanam Parikh
- Director
- --
- Vincent LoPriore
- Director
- --
- Kelly J. Anderson
- Independent Director
- 46.17K
- Leonard L. Mazur
- Independent Director
- 34.43K
- Dr. Lynne A. Bui, M.D.
- Independent Director
- 41.57K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀